Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity
- PMID: 22313963
- DOI: 10.1097/QAD.0b013e328351f7a5
Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity
Abstract
Objective and design: Treatment of human immunodeficiency virus (HIV)-infected women with the highly active antiretroviral therapy (HAART) has reduced the onset of uterine cervical intraepithelial neoplasia (CIN), and halted its progression to cervical carcinoma. We and others demonstrated that the HIV protease inhibitors (HIV-PIs) used in HAART can exert direct antitumour activities also in HIV-free preclinical or clinical models. As uterine cervical carcinoma is a leading cause of death in women independently of HIV infection, herein we assessed the impact of therapeutic concentrations of HIV-PIs including indinavir (IDV), saquinavir (SQV) or ritonavir (RTV) on cells obtained from CIN or cervical carcinoma lesions of HIV-negative women.
Methods: HIV-PI effects were evaluated by cell invasion, growth or toxicity assays, and by RNA, protein or zymogram analyses.
Results: Both SQV and RTV inhibited CIN cell invasion, and this was paralleled by a reduced expression and proteolytic activity of the matrix metalloproteinase (MMP)-2 and 9 in treated cells. SQV and RTV also reduced CIN cell growth rate, but did not affect the invasion or growth of cells derived from highly progressed cervical carcinoma.
Conclusion: As MMP-2 and MMP-9 have a key role in CIN evolution into cervical carcinoma, these results support the use of SQV or RTV for the block of CIN clinical progression in either HIV-infected or uninfected patients.
Comment in
-
HIV protease inhibitors to prevent progression of cervical intraepithelial neoplasia to cervical cancer: therapeutic opportunities and challenges.AIDS. 2012 May 15;26(8):1035-6. doi: 10.1097/QAD.0b013e328352ae2f. AIDS. 2012. PMID: 22552478 No abstract available.
Similar articles
-
Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells.Oncol Lett. 2017 May;13(5):2903-2908. doi: 10.3892/ol.2017.5835. Epub 2017 Mar 9. Oncol Lett. 2017. PMID: 28521396 Free PMC article.
-
HIV protease inhibitors to prevent progression of cervical intraepithelial neoplasia to cervical cancer: therapeutic opportunities and challenges.AIDS. 2012 May 15;26(8):1035-6. doi: 10.1097/QAD.0b013e328352ae2f. AIDS. 2012. PMID: 22552478 No abstract available.
-
HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.Mol Cancer Ther. 2020 Dec;19(12):2476-2489. doi: 10.1158/1535-7163.MCT-20-0055. Epub 2020 Oct 20. Mol Cancer Ther. 2020. PMID: 33082275
-
The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.Int J Mol Sci. 2018 May 9;19(5):1418. doi: 10.3390/ijms19051418. Int J Mol Sci. 2018. PMID: 29747434 Free PMC article. Review.
-
HIV-1 protease inhibitors. A review for clinicians.JAMA. 1997 Jan 8;277(2):145-53. JAMA. 1997. PMID: 8990341 Review.
Cited by
-
HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins.Cancers (Basel). 2021 Feb 24;13(5):949. doi: 10.3390/cancers13050949. Cancers (Basel). 2021. PMID: 33668328 Free PMC article.
-
Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities.Front Mol Biosci. 2022 May 10;9:875208. doi: 10.3389/fmolb.2022.875208. eCollection 2022. Front Mol Biosci. 2022. PMID: 35620479 Free PMC article. Review.
-
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Oncotarget. 2014 Sep 30;5(18):8052-82. doi: 10.18632/oncotarget.2408. Oncotarget. 2014. PMID: 25211298 Free PMC article.
-
Entrance of the Tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels.Oncol Lett. 2016 Oct;12(4):2389-2394. doi: 10.3892/ol.2016.4921. Epub 2016 Jul 29. Oncol Lett. 2016. PMID: 27698804 Free PMC article.
-
Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells.Oncol Lett. 2017 May;13(5):2903-2908. doi: 10.3892/ol.2017.5835. Epub 2017 Mar 9. Oncol Lett. 2017. PMID: 28521396 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous